Phase III Study

Investigational drugs opaganib and RHB-107 (upamostat) demonstrate distinct synergistic effect when combined individually with remdesivir, significantly improving...

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that the new drug application of...